নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - sunitinib 12.5mg - capsule - 12.5 mg - active: sunitinib 12.5mg excipient: croscarmellose sodium gelatin printing ink, white iron oxide red magnesium stearate mannitol microcrystalline cellulose povidone titanium dioxide - treatment of advanced renal cell carcinoma

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - sunitinib 25mg - capsule - 25 mg - active: sunitinib 25mg excipient: croscarmellose sodium gelatin printing ink, white iron oxide black iron oxide red iron oxide yellow magnesium stearate mannitol microcrystalline cellulose povidone titanium dioxide - treatment of advanced renal cell carcinoma

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - sunitinib 37.5mg - capsule - 37.5 mg - active: sunitinib 37.5mg excipient: croscarmellose sodium gelatin printing ink, black iron oxide yellow magnesium stearate mannitol microcrystalline cellulose povidone titanium dioxide - treatment of advanced renal cell carcinoma

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - sunitinib 50mg - capsule - 50 mg - active: sunitinib 50mg excipient: croscarmellose sodium gelatin printing ink, white iron oxide black iron oxide red iron oxide yellow magnesium stearate mannitol microcrystalline cellulose povidone titanium dioxide - treatment of advanced renal cell carcinoma

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - glyceryl trinitrate 50mg (releasing 10mg/24h) - transdermal patch - 10 mg/24h - active: glyceryl trinitrate 50mg (releasing 10mg/24h) - treatment of angina pectoris as monotherapy or in combination with other anti-anginal drugs such as beta-blockers and/or calcium antagonists.

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - glyceryl trinitrate 25mg (releasing 5mg/24h) - transdermal patch - 5 mg/24h - active: glyceryl trinitrate 25mg (releasing 5mg/24h) - treatment of angina pectoris as monotherapy or in combination with other anti-anginal drugs such as beta-blockers and/or calcium antagonists.

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - adalimumab 50 mg/ml - solution for injection - 40 mg/0.8ml - active: adalimumab 50 mg/ml excipient: adipic acid citric acid monohydrate hydrochloric acid mannitol polysorbate 80 sodium chloride sodium hydroxide water for injection - rheumatoid arthritis hyrimoz is indicatedfor reducing signs and symptoms, as well as inhibiting the progression of structural damage in adult patients with moderate to severely active rheumatoid arthritis. this includes the treatment of patients with recently diagnosed moderate to severely active disease who have not received methotrexate. hyrimoz can be used alone or in combination with methotrexate.

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - adalimumab 50 mg/ml - solution for injection - 40 mg/0.8ml - active: adalimumab 50 mg/ml excipient: adipic acid citric acid monohydrate hydrochloric acid mannitol polysorbate 80 sodium chloride sodium hydroxide water for injection - rheumatoid arthritis hyrimoz is indicatedfor reducing signs and symptoms, as well as inhibiting the progression of structural damage in adult patients with moderate to severely active rheumatoid arthritis. this includes the treatment of patients with recently diagnosed moderate to severely active disease who have not received methotrexate. hyrimoz can be used alone or in combination with methotrexate.

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - adalimumab 50 mg/ml - solution for injection - 20 mg/0.4ml - active: adalimumab 50 mg/ml excipient: adipic acid citric acid monohydrate hydrochloric acid mannitol polysorbate 80 sodium chloride sodium hydroxide water for injection - rheumatoid arthritis hyrimoz is indicatedfor reducing signs and symptoms, as well as inhibiting the progression of structural damage in adult patients with moderate to severely active rheumatoid arthritis. this includes the treatment of patients with recently diagnosed moderate to severely active disease who have not received methotrexate. hyrimoz can be used alone or in combination with methotrexate.

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - cefalexin monohydrate 525.8mg equivalent to cephalexin 500 mg;   - capsule - 500 mg - active: cefalexin monohydrate 525.8mg equivalent to cephalexin 500 mg   excipient: gelatin   magnesium stearate microcrystalline cellulose titanium dioxide   water